Tourmaline Oil Corp. (TOU)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 67.33 |
|---|---|
| 52-week range | 57.95 – 70.57 |
| Return, 1 month / 3 months | +9.7% / +6.8% |
| Return, 1 year / 3 years | +12.4% / +7.4% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 25.4% |
| Worst drawdown (1 year) | -14.5% |
| Average daily value traded | 141.43M CAD |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tourmaline Oil Corp. is a Canadian energy company that explores for and produces natural gas, natural gas liquids and crude oil. Its operations are concentrated in the Western Canadian Sedimentary Basin, chiefly in the Montney and Deep Basin areas of Alberta and British Columbia. The company supplies these commodities to energy markets and has expanded its production base partly through acquisitions of other producers. Tourmaline Oil Corp. is based in Calgary, Alberta.
The shares are listed on the Toronto Stock Exchange in Canada under the code TOU, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tourmaline Oil Corp. (TOU) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 67.33 on 27 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 81 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.4% and over the last three months it rose 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -3.2% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.8% | ||
| 6-month return | 8.8% | ||
| 12-month return, skipping the last month | 2.5% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.5% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 141.43M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +9.7% |
| 3 months | +6.8% |
| 6 months | +8.8% |
| 1 year | +12.4% |
| 3 years | +7.4% |
| 5 years | +116.3% |
Signals
| 50-day / 200-day average | 62.63 / 62.17 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Dec 2026 | CAD 0.5250 |
| 15 Sep 2026 | CAD 0.5000 |
| 15 Jun 2026 | CAD 0.5000 |
| 16 Mar 2026 | CAD 0.5000 |
| 15 Dec 2025 | CAD 0.5000 |
| 14 Nov 2025 | CAD 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.